We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reinforcing Exercise in Substance Abusing Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01204879
First Posted: September 17, 2010
Last Update Posted: June 26, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
UConn Health
  Purpose
This study will evaluate the efficacy of an exercise-based contingency management (CM) intervention. A total of 120 substance abusing patients in intensive outpatient treatment will be randomly assigned to one of two conditions: (a) standard care plus CM for completing goal-related activities not related to exercising (e.g., improving work, family, or transportation issues), or (b) standard care plus CM for completing exercise-related activities. Compared to those receiving goal-related CM activity contracting, it is expected that those in the exercise CM condition will participate in more physical activities and develop greater strength and flexibility, decrease drug use, reduce HIV risk behaviors, lessen depressive symptoms, and improve health indices.

Condition Intervention
Substance Abuse Contingency Management Exercise Behavioral: Contingency Management

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Reinforcing Exercise in Substance Abusing Patients

Resource links provided by NLM:


Further study details as provided by UConn Health:

Primary Outcome Measures:
  • physical activity participation and functioning measured by the PAQ (Kcal/wk expenditures) [ Time Frame: baseline ]
  • physical activity participation and functioning measured by the PAQ (Kcal/wk expenditures) [ Time Frame: month 2 ]
  • physical activity participation and functioning measured by the PAQ (Kcal/wk expenditures) [ Time Frame: month 4 ]
  • physical activity participation and functioning measured by the PAQ (Kcal/wk expenditures) [ Time Frame: month 6 ]
  • physical activity participation and functioning measured by the PAQ (Kcal/wk expenditures) [ Time Frame: month 9 ]
  • physical activity participation and functioning measured by the PAQ (Kcal/wk expenditures) [ Time Frame: month 12 ]
  • attendance at exercise classes [ Time Frame: baseline ]
  • attendance at exercise classes [ Time Frame: month 2 ]
  • attendance at exercise classes [ Time Frame: month 4 ]
  • attendance at exercise classes [ Time Frame: month 6 ]
  • attendance at exercise classes [ Time Frame: month 9 ]
  • attendance at exercise classes [ Time Frame: month 12 ]

Secondary Outcome Measures:
  • longest duration of abstinence [ Time Frame: baseline ]
  • longest duration of abstinence [ Time Frame: month 2 ]
  • longest duration of abstinence [ Time Frame: month 4 ]
  • longest duration of abstinence [ Time Frame: month 6 ]
  • longest duration of abstinence [ Time Frame: month 9 ]
  • longest duration of abstinence [ Time Frame: month 12 ]
  • HIV risk behaviors as reported on HRBS questionnaire [ Time Frame: baseline ]
  • HIV risk behaviors as reported on HRBS questionnaire [ Time Frame: month 2 ]
  • HIV risk behaviors as reported on HRBS questionnaire [ Time Frame: month 4 ]
  • HIV risk behaviors as reported on HRBS questionnaire [ Time Frame: month 6 ]
  • HIV risk behaviors as reported on HRBS questionnaire [ Time Frame: month 9 ]
  • HIV risk behaviors as reported on HRBS questionnaire [ Time Frame: month 12 ]
  • psychological distress as reported on BSI questionnaire [ Time Frame: baseline ]
  • psychological distress as reported on BSI questionnaire [ Time Frame: month 2 ]
  • psychological distress as reported on BSI questionnaire [ Time Frame: month 4 ]
  • psychological distress as reported on BSI questionnaire [ Time Frame: month 6 ]
  • psychological distress as reported on BSI questionnaire [ Time Frame: month 9 ]
  • psychological distress as reported on BSI questionnaire [ Time Frame: month 12 ]

Enrollment: 120
Study Start Date: April 2010
Study Completion Date: July 2015
Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: CM for general activities
Standard care plus individual contingency management session for general activities
Behavioral: Contingency Management
Participants earn the chance to win prizes for the targeted behavior.
Experimental: CM for exercise-related activities
Standard care plus individual contingency management session for physical activities
Behavioral: Contingency Management
Participants earn the chance to win prizes for the targeted behavior.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age 18-65 years
  • English speaking
  • in substance abuse treatment
  • written permission from a physician (or their designated health care professional, e.g., nurse, physicians assistant) to participate in the study and an exercise program.

Exclusion Criteria:

  • inability to comprehend the study
  • in recovery for pathological gambling
  • contraindication for exercising
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01204879


Locations
United States, Connecticut
Alcohol and Drug Recovery Centers, Inc.
Hartford, Connecticut, United States, 60112
Sponsors and Collaborators
UConn Health
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Nancy M Petry, Ph.D. University of Conncecticut Health Center
  More Information

Responsible Party: UConn Health
ClinicalTrials.gov Identifier: NCT01204879     History of Changes
Other Study ID Numbers: 10-010S-2
R01DA027615 ( U.S. NIH Grant/Contract )
First Submitted: August 9, 2010
First Posted: September 17, 2010
Last Update Posted: June 26, 2017
Last Verified: December 2016

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders